We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-5%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.45B
AUM Growth
+$12.9M
(+0.9%)
Cap. Flow
+$99.9M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
34.13%
Holding
1,140
New
132
Increased
492
Reduced
188
Closed
50
Avg Time Held
2.9
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$23.9M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$18.8M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$14.2M |
| 4 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$13.4M |
| 5 |
Apple
AAPL
|
+$6.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$24.4M |
| 2 |
iShares Gold Trust
IAU
|
+$8.75M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.91M |
| 4 |
Ally Financial
ALLY
|
+$4.53M |
| 5 |
Newmont
NEM
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.9% |
| 2 | Technology | 6.89% |
| 3 | Healthcare | 4.85% |
| 4 | Financials | 4% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
Linde
LIN
$230B
| $2K | ﹤0.01% |
+7
| New | +$2.01K |
2022 Q3
0 quarters
|
|
1002
Lam Research
LRCX
$330B
| $2K | ﹤0.01% |
+50
| New | +$2.23K |
2022 Q3
0 quarters
|
|
1003
Mesabi Trust
MSB
$235M
| $2K | ﹤0.01% |
111
+3
| +3% | +$77 |
2022 Q2
1 quarter
|
|
1004
ArcelorMittal
MT
$47.4B
| $2K | ﹤0.01% |
119
| – | – |
2021 Q1
6 quarters
|
|
1005
MGIC Investment
MTG
$5.71B
| $2K | ﹤0.01% |
+142
| New | +$1.99K |
2022 Q3
0 quarters
|
|
1006
Nuveen Quality Municipal Income Fund
NAD
$2.42B
| $2K | ﹤0.01% |
150
| – | – |
2022 Q1
2 quarters
|
|
1007
Norwegian Cruise Line
NCLH
$6.91B
| $2K | ﹤0.01% |
154
+54
| +54% | +$711 |
2022 Q2
1 quarter
|
|
1008
NetApp
NTAP
$40B
| $2K | ﹤0.01% |
28
| – | – |
2021 Q1
6 quarters
|
|
1009
Northern Trust
NTRS
$30.3B
| $2K | ﹤0.01% |
+19
| New | +$1.83K |
2022 Q3
0 quarters
|
|
1010
Pentair
PNR
$8.53B
| $2K | ﹤0.01% |
50
+32
| +178% | +$1.48K |
2021 Q1
6 quarters
|
|
1011
DELISTED
PROS Holdings
PRO
| $2K | ﹤0.01% |
100
| – | – |
2022 Q2
1 quarter
|
|
1012
Regal Rexnord
RRX
$10.3B
| $2K | ﹤0.01% |
+12
| New | +$1.61K |
2022 Q3
0 quarters
|
|
1013
Revvity
RVTY
$17B
| $2K | ﹤0.01% |
20
+10
| +100% | +$1.41K |
2021 Q3
4 quarters
|
|
1014
Snap
SNAP
$10.4B
| $2K | ﹤0.01% |
+156
| New | +$1.81K |
2022 Q3
0 quarters
|
|
1015
Teladoc Health
TDOC
$1.03B
| $2K | ﹤0.01% |
84
-28
| -25% | -$982 |
2020 Q1
10 quarters
|
|
1016
Teradyne
TER
$50.8B
| $2K | ﹤0.01% |
+23
| New | +$2.1K |
2022 Q3
0 quarters
|
|
1017
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
| $2K | ﹤0.01% |
196
| – | – |
2021 Q1
6 quarters
|
|
1018
Tyson Foods
TSN
$19.3B
| $2K | ﹤0.01% |
+32
| New | +$2.53K |
2022 Q3
0 quarters
|
|
1019
Trade Desk
TTD
$5.78B
| $2K | ﹤0.01% |
30
| – | – |
2020 Q1
10 quarters
|
|
1020
Uniti Group
UNIT
$1.36B
| $2K | ﹤0.01% |
168
+3
| +2% | +$28 |
2021 Q1
6 quarters
|
|
1021
VF Corp
VFC
$6.62B
| $2K | ﹤0.01% |
73
+1
| +1% | +$43 |
2021 Q1
6 quarters
|
|
1022
Vident International Equity Strategy
VIDI
$439M
| $2K | ﹤0.01% |
106
| – | – |
2019 Q2
13 quarters
|
|
1023
Western Digital
WDC
$124B
| $2K | ﹤0.01% |
78
| – | – |
2019 Q1
14 quarters
|
|
|
CAJ
1024
DELISTED
Canon, Inc.
CAJ
| $2K | ﹤0.01% |
87
+1
| +1% | +$24 |
2022 Q2
1 quarter
|
|
1025
Albemarle
ALB
$11.3B
| $1K | ﹤0.01% |
+4
| New | +$1.02K |
2022 Q3
0 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Analysts LLC held 1,140 positions worth $1.45B, up 0.9% from $1.44B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Analysts LLC deployed $99.9M of net new capital in Q3 2022, opening 132 new positions and adding to 492 existing holdings. Its largest new stake was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $24.4M trimmed.
- Capital Analysts LLC's largest Q3 2022 buy was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
- Capital Analysts LLC added most to JPMorgan Ultra-Short Income ETF in Q3 2022, an estimated $23.9M increase.
- Capital Analysts LLC's biggest Q3 2022 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $24.4M.
- Capital Analysts LLC fully exited Ally Financial in Q3 2022, selling an estimated $4.53M.
- Capital Analysts LLC's ten largest holdings make up 34% of its $1.45B portfolio in Q3 2022.
- Capital Analysts LLC opened 132 new positions and closed 50 in Q3 2022.
- Capital Analysts LLC's portfolio value rose 0.9% quarter-over-quarter to $1.45B.
Based on Capital Analysts LLC's 13F filing for Q3 2022, filed 14 Nov 2022.